CAFs secrete high levels of the ligands IGF1 and IGF2, thereby promoting the tumor growth, migration, and invasion as well as drug resistance of IGF1R-expressing tumor cells [72,73,74]. The gene discussed is IGF1R; the disease is neoplasm.